Patents by Inventor Steven G Griffiths

Steven G Griffiths has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hsp60 from arthrobacter
    Patent number: 7297783
    Abstract: The hsp60 gene from a strain of Arthrobacter has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.
    Type: Grant
    Filed: February 13, 2004
    Date of Patent: November 20, 2007
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Steven G Griffiths, Rachael J Ritchie, Nathalie C Simard
  • Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
    Patent number: 7201910
    Abstract: The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anaemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: April 10, 2007
    Assignees: Novartis AG, Ottawa Health Research Institute
    Inventors: Steven G Griffiths, Rachael J Ritchie
  • Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
    Patent number: 7199108
    Abstract: The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anaemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: April 3, 2007
    Assignees: Novartis AG, Ottawa Health Research Institute
    Inventors: Steven G Griffiths, Rachael J Ritchie, Joel Heppell